Effect of the overexpression of wild‐type or mutant α‐synuclein on cell susceptibility to insult
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
Mutations in α‐synuclein (A30P and A53T) are involved in some cases of familial Parkinson's disease (FPD), but it is not known how they result in nigral cell death. We examined the effect of α‐synuclein overexpression on the response of cells to various insults. Wild‐type α‐synuclein and α‐synuclein mutations associated with FPD were overexpressed in NT‐2/D1 and SK‐N‐MC cells. Overexpression of wild‐type α‐synuclein delayed cell death induced by serum withdrawal or H 2 O 2, but did not delay cell death induced by 1‐methyl‐4‐phenylpyridinium ion (MPP+). By contrast, wild‐type α‐synuclein transfectants were sensitive to viability loss induced by staurosporine, lactacystin or 4‐hydroxy‐2‐trans‐nonenal (HNE). Decreases in glutathione (GSH) levels were attenuated by wild‐type α‐synuclein after serum deprivation, but were aggravated following lactacystin or staurosporine treatment. Mutant α‐synucleins increased levels of 8‐hydroxyguanine, protein carbonyls, lipid peroxidation and 3‐nitrotyrosine, and markedly accelerated cell death in response to all the insults examined. The decrease in GSH levels was enhanced in mutant α‐synuclein transfectants. The loss of viability induced by toxic insults was by apoptosic mechanism. The presence of abnormal α‐synucleins in substantia nigra in PD may increase neuronal vulnerability to a range of toxic agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Antibodies, a laboratory manual
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90130-3 · Cited by 12,366
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240 · cited 7×
“Wild-type a-synuclein and a-synuclein mutations associated with FPD were overexpressed in NT-2/D1 and SK-N-MC cells.”
BackgroundInfluentialA fluorometric method for determination of oxidized and reduced glutathione in tissues
Hissin, P. J., & Hilf, R. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90326-2 · Cited by 4,108
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836 · cited 1×
“Two mutated a-synuclein proteins (A30P and A53T) have been found in some cases of FPD (Polymeropoulos et al. 1997; Kruger et al. 1998).”
BackgroundSpillantini, M. G., Crowther, R. A., Jakes, R., Hasegawa, M., & Goedert, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6469 · Cited by 2,868 · cited 2×
“Abnormal staining for a-synuclein is found in neuro®lament inclusions in multisystem atrophy (Spillantini et al. 1998b) and in Alzheimer's disease (Goedert et al. 1998).”
Background[38] Oxidative damage to proteins: Spectrophotometric method for carbonyl assay
Reznick, A. Z., & Packer, L. (1994) · Methods in Enzymology · doi:10.1016/s0076-6879(94)33041-7 · Cited by 2,452
Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A., Sagara, Y., Sisk, A., & Mucke, L. (2000) · Science · doi:10.1126/science.287.5456.1265 · Cited by 1,765 · cited 1×
“It seems that function of wild-type a-synuclein is cell line- and insult-speci®c, since many previous studies suggest both protective and non-protective properties (Da Costa et al. 2000; Masliah et al. 2000; Zhou et al. 2000).”
ResultSynuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal
Maroteaux, L., Campanelli, J., & Scheller, R. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-08-02804.1988 · Cited by 1,641 · cited 1×
“They also raised baseline levels of some parameters of oxidative stress. a-Synuclein is one of the abundant proteins in cells (Maroteaux et al. 1988).”
BackgroundIdentification of two distinct synucleins from human brain
Jakes, R., Spillantini, M. G., & Goedert, M. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00395-5 · Cited by 1,080 · cited 2×
“The amino terminal region contains ®ve consensus sequence repeats, `KTKEGV' and the carboxyl terminal is rich in acidic amino acids (Jakes et al. 1994). a-Synuclein is present in Lewy bodies, which are a characteristic feature of PD, and of dementia with Lewy body disease (Spillantini et al. 1998a).”
BackgroundMechanism of Cellular 3‐(4,5‐Dimethylthiazol‐2‐yl)‐2,5‐Diphenyltetrazolium Bromide (MTT) Reduction
Liu, Y., Peterson, D. A., Kimura, H., & Schubert, D. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69020581.x · Cited by 1,034 · cited 1×
“Reduction of MTT is largely dependent on the degree of mitochondrial activity in cells (Liu et al. 1997).”
BackgroundGrazia Spillantini, M., Anthony Crowther, R., Jakes, R., Cairns, N. J., Lantos, P. L., & Goedert, M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00504-7 · Cited by 1,025
Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease.
Yoritaka, A., Hattori, N., Uchida, K., Tanaka, M., Stadtman, E. R., & Mizuno, Y. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.7.2696 · Cited by 981 · cited 4×
“The latter is a toxic unsaturated aldehyde produced during lipid peroxidation and which is present in increased amounts in parkinsonian substantia nigra (Yoritaka et al. 1996).”
BackgroundInfluentialAlam, Z. I., Jenner, A., Daniel, S. E., Lees, A. J., Cairns, N., Marsden, C. D., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031196.x · Cited by 845
Self-citationOliver, C. N., Starke-Reed, P. E., Stadtman, E. R., Liu, G. J., Carney, J. M., & Floyd, R. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.13.5144 · Cited by 771
Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones.
Biedler, J. L., Roffler-Tarlov, S. K., Schachner, M., & Freedman, L. S. (1978) · PubMed · Cited by 759
Understanding cell death in parkinson's disease
Jenner, P., & Olanow, C. W. (1998) · Annals of Neurology · doi:10.1002/ana.410440712 · Cited by 685
Self-citationAlam, Z. I., Daniel, S. E., Lees, A. J., Marsden, D. C., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031326.x · Cited by 547
Self-citationLyras, L., Cairns, N. J., Jenner, A., Jenner, P., & Halliwell, B. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052061.x · Cited by 531 · cited 1×
“DNA extraction and assessment of purity were carried out as described by Lyras et al. (1997).”
MethodSelf-citationNeuropathology in mice expressing human alpha-synuclein
van der Putten, H., Wiederhold, K., Probst, A., Barbieri, S., Mistl, C., Danner, S., Kauffmann, S., Hofele, K., Spooren, W. P. J. M., Rüegg, M. A., et al. (2000) · PubMed · doi:10.5451/unibas-ep2767 · Cited by 505
Neuropathology in Mice Expressing Human α-Synuclein
van der Putten, H., Wiederhold, K.-H., Probst, A., Barbieri, S., Mistl, C., Danner, S., Kauffmann, S., Hofele, K., Spooren, W. P. J. M., Ruegg, M. A., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06021.2000 · Cited by 477 · cited 1×
“…are hypersensitive to damage by 6-hydroxydopamine (Kholodilov et al. 1999) and other insults (Saha et al. 2000), and this has been observed in studies with primary culture and transgenic mice (Da Costa et al. 2000; Ostrerova-Golts et al. 2000; Van der Putten et al. 2000; Zhou et al. 2000).”
BackgroundWhat nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo?
Halliwell, B. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00469-9 · Cited by 472 · cited 1×
“Using an ELISA assay, basal levels of protein-bound 3-nitrotyrosine, a biomarker of attack of ONOO2 upon proteins (Halliwell 1997), were detectable in both cell lines (Fig.”
MethodSelf-citationThe A53T α-Synuclein Mutation Increases Iron-Dependent Aggregation and Toxicity
Ostrerova-Golts, N., Petrucelli, L., Hardy, J., Lee, J. M., Farer, M., & Wolozin, B. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06048.2000 · Cited by 466 · cited 1×
“…are hypersensitive to damage by 6-hydroxydopamine (Kholodilov et al. 1999) and other insults (Saha et al. 2000), and this has been observed in studies with primary culture and transgenic mice (Da Costa et al. 2000; Ostrerova-Golts et al. 2000; Van der Putten et al. 2000; Zhou et al. 2000).”
BackgroundOxidative stress induces amyloid-like aggregate formation of NACP/α-synuclein in vitro
Hashimoto, M., Hsu, L. J., Xia, Y., Takeda, A., Sisk, A., Sundsmo, M., & Masliah, E. (1999) · NeuroReport · doi:10.1097/00001756-199903170-00011 · Cited by 429 · cited 2×
“Oxidative stress may also promote the aggregation of a-synuclein (Hashimoto et al. 1999a).”
BackgroundDegradation of α-Synuclein by Proteasome
Bennett, M. C., Bishop, J. F., Leng, Y., Chock, P. B., Chase, T. N., & Mouradian, M. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.33855 · Cited by 417
Lactacystin, Proteasome Function, and Cell Fate
Fenteany, G., & Schreiber, S. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.8545 · Cited by 410
Proteolysis in Cultured Liver Epithelial Cells during Oxidative Stress
Grune, T., Reinheckel, T., Joshi, M., & Davies, K. J. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.5.2344 · Cited by 407 · cited 2×
“Interestingly, it has been suggested that HNEmodi®ed proteins can also block the proteasome system (Grune et al. 1995), which would be consistent with the results we obtained on addition of this substance.”
BackgroundResultMattila, P. M., Rinne, J. O., Helenius, H., Dickson, D. W., Röyttä, M., & Mattila, P. M. (2000) · Acta Neuropathologica · doi:10.1007/s004019900168 · Cited by 361
Yermilov, V., Rubio, J., & Ohshima, H. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)01281-6 · Cited by 357 · cited 2×
“Peroxynitrite (ONOO(2)) was prepared in a quenched ̄ow reaction system (Yermilov et al. 1995).”
MethodGlutathione‐related enzymes in brain in Parkinson's disease
Sian, J., Dexter, D. T., Lees, A. J., Daniel, S., Jenner, P., & Marsden, C. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360306 · Cited by 296 · cited 1×
“There is considerable evidence that oxidative stress is associated with the progression of sporadic PD and may be an early stage in its development (Sian et al. 1994; Beal 1997; Jenner and Olanow 1998).”
BackgroundSelf-citationParkinson disease: A new link between monoamine oxidase and mitochondrial electron flow
Cohen, G., Farooqui, R., & Kesler, N. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.10.4890 · Cited by 286 · cited 1×
“H2O2 is generated in increased amounts by monoamine oxidase activity in parkinsonian substantia nigra (Cohen et al. 1997).”
BackgroundMcLeod, M., Stein, M., & Beach, D. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb04814.x · Cited by 254
Björklund, A., Rosenblad, C., Winkler, C., & Kirik, D. (1997) · Neurobiology of Disease · doi:10.1006/nbdi.1997.0151 · Cited by 248 · cited 1×
“Serum deprivation is a widely used model for neurotrophic factor deprivation, and such factors are being widely investigated as neuroprotective agents (Bjorklund et al. 1997).”
Background3-Nitrotyrosine in the proteins of human plasma determined by an ELISA method
KHAN, J., BRENNAN, M. D., BRADLEY, N., GAO, B., BRUCKDORFER, R., & JACOBS, M. (1998) · Biochemical Journal · doi:10.1042/bj3300795 · Cited by 247 · cited 1×
“Measurement of 3-nitrotyrosine content was carried out as described by Khan et al. (1998).”
MethodSinger, T. P., Castagnoli, N., Ramsay, R. R., & Trevor, A. J. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb03384.x · Cited by 244
Role of Cytochrome c as a Stimulator of α-Synuclein Aggregation in Lewy Body Disease
Hashimoto, M., Takeda, A., Hsu, L. J., Takenouchi, T., & Masliah, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.41.28849 · Cited by 236
da Costa, C. A., Ancolio, K., & Checler, F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002413200 · Cited by 213 · cited 2×
“It seems that function of wild-type a-synuclein is cell line- and insult-speci®c, since many previous studies suggest both protective and non-protective properties (Da Costa et al. 2000; Masliah et al. 2000; Zhou et al. 2000).”
BackgroundResultZhou, W., Hurlbert, M. S., Schaack, J., Prasad, K. N., & Freed, C. R. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02215-0 · Cited by 204
Alpha synuclein in neurodegenerative disorders: Murderer or accomplice?
Mezey, E., Dehejia, A., Harta, G., Papp, M. I., Polymeropoulos, M. H., & Brownstein, M. J. (1998) · Nature Medicine · doi:10.1038/nm0798-755 · Cited by 184 · cited 3×
“The mutant a-synucleins have been suggested to self-aggregate, and to aggregate with wild-type a-synuclein and other proteins, to give insoluble deposits that cannot undergo proteolysis by the proteasome (Mezey et al. 1998).”
BackgroundApoptosis in neurodegenerative disorders
Stefanis, L., Burke, R. E., & Greene, L. A. (1997) · Current Opinion in Neurology · doi:10.1097/00019052-199708000-00004 · Cited by 177 · cited 1×
“There is growing evidence that apoptosis contributes to neuronal cell death in substantia nigra in PD (Stefani et al. 1997).”
Background[32] High-performance liquid chromatography-based thiorbarbituric acid tests
Chirico, S. (1994) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(94)33035-2 · Cited by 174 · cited 3×
“Lipid peroxidation The level of lipid peroxidation in the cells was assessed by using a thiobarbituric acid (TBA)-based test linked to HPLC to remove interfering chromogens (Chirico 1994).”
BackgroundMethodInfluentialProteasome‐dependent degradation of oxidized proteins in MRC‐5 fibroblasts
Sitte, N., Merker, K., & Grune, T. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01495-1 · Cited by 172 · cited 2×
“A rise in protein carbonyls in lactacystin-treated cells has already been reported (Sitte et al. 1998), consistent with the degradation of oxidatively modi®ed proteins by this mechanism.”
BackgroundResultInduction of neuronal death by α‐synuclein
Saha, A. R., Ninkina, N. N., Hanger, D. P., Anderton, B. H., Davies, A. M., & Buchman, V. L. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00210.x · Cited by 169 · cited 1×
“…dopaminergic neurons expressing mutated a-synuclein are hypersensitive to damage by 6-hydroxydopamine (Kholodilov et al. 1999) and other insults (Saha et al. 2000), and this has been observed in studies with primary culture and transgenic mice (Da Costa et al. 2000; Ostrerova-Golts et al. 2000;…”
BackgroundMeasurement of oxidized and methylated DNA bases by HPLC with electrochemical detection
Kaur, H., & Halliwell, B. B. (1996) · Biochemical Journal · doi:10.1042/bj3180021 · Cited by 149 · cited 1×
“DNA hydrolysis with formic acid and separation of modi®ed 8-hydroxyguanine (8-OHG) by HPLC were performed as described by Kaur and Halliwell (1996).”
MethodSelf-citationLyras, L., Perry, R. H., Perry, E. K., Ince, P. G., Jenner, A., Jenner, P., & Halliwell, B. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.71010302.x · Cited by 121 · cited 1×
“For measuring lipid damage, thiobarbituric acid (TBA) reactive material was measured by HPLC as described by Lyras et al. (1998), employing 3 106 cells.”
MethodSelf-citationEl‐Agnaf, O. M. A., & Irvine, G. B. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4262 · Cited by 102 · cited 1×
“It may result in accumulation and aggregation of normal and abnormal proteins in cytoplasm, as shown in previous studies (El-Agnaf and Irvine 2000; Mattila et al. 2000).”
ResultOxidative Damage in Neurodegenerative Diseases
Beal, M. F. (1997) · The Neuroscientist · doi:10.1177/107385849700300112 · Cited by 89
Ahlemeyer, B., & Krieglstein, J. (2000) · Neurochemistry International · doi:10.1016/s0197-0186(99)00101-1 · Cited by 77 · cited 1×
“Somewhat similar data were obtained with staurosporine, a protein kinase inhibitor that is widely used to induce apoptosis, accompanied by oxidative stress (Ahlemeyer and Krieglstein 2000).”
Lyras, L. A., Evans, P. J., Shaw, P. J., Ince, P. G., & Halliwell, B. (1996) · Free Radical Research · doi:10.3109/10715769609088038 · Cited by 76 · cited 1×
“Protein carbonyl content was determined by method A of Lyras et al. (1996), except that the ®nal protein pellets were dissolved in 1 mL of 6 m guanidinium hydrochloride.”
MethodSelf-citationKholodilov, N. G., Oo, T. F., & Burke, R. E. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00740-5 · Cited by 65
Angulo, A., Suto, C. M., Boehm, M. F., Heyman, R. A., & Ghazal, P. (1995) · Journal of Virology · doi:10.1128/jvi.69.6.3831-3837.1995 · Cited by 47 · cited 2×
“Cell culture NT-2 is a human teratocarcinoma cell line (Angulo et al. 1995) and SK-N-MC is a human neuroblastoma cell line, which has cholinergic characteristics (Biedler et al.”
BackgroundImpaired clearance of oxidised proteins in neurodegenerative diseases
Halliwell, B. B., & Jenner, P. G. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78898-x · Cited by 45 · cited 2×
“1998) and there is evidence for impairments of proteasome function in the neurodegenerative diseases (Halliwell and Jenner 1998).”
BackgroundSelf-citationMitochondria in the aetiology and pathogenesis of Parkinson's disease
Schapira, A. H. V. (1999) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(99)00029-2 · Cited by 45 · cited 2×
“Defects in mitochondria, especially complex I, have also been reported and may themselves lead to further oxidative stress (Schapira 1999).”
3-Nitrotyrosine in the proteins of human plasma determined by an ELISA method
KHAN, J., BRENNAND, D. M., BRADLEY, N., GAO, B., BRUCKDORFER, R., & JACOBS, M. (1998) · Biochemical Journal · doi:10.1042/bj3320807v · Cited by 44
Whiteman, M., & Halliwell, B. B. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0564 · Cited by 41 · cited 1×
“Nitrated BSA was prepared by using a method described by Whiteman and Halliwell (1999).”
MethodSelf-citationIntraneuronal filamentous tau protein and α-synuclein deposits in neurodegenerative diseases
Goedert, M., Jakes, R., Crowther, R. A., Hasegawa, M., Smith, M. J., & Spillantini, M. G. (1998) · Biochemical Society Transactions · doi:10.1042/bst0260463 · Cited by 38 · cited 1×
“Abnormal staining for a-synuclein is found in neuro®lament inclusions in multisystem atrophy (Spillantini et al. 1998b) and in Alzheimer's disease (Goedert et al. 1998).”
Background
Cited by
Oxidative stress in Parkinson's disease
Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053
Self-citationMOLECULAR PATHOPHYSIOLOGY OF PARKINSON'S DISEASE
Moore, D. J., West, A. B., Dawson, V. L., & Dawson, T. M. (2005) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.28.061604.135718 · Cited by 1,280
The Ubiquitin Proteasome System in Neurodegenerative Diseases
Ciechanover, A., & Brundin, P. (2003) · Neuron · doi:10.1016/s0896-6273(03)00606-8 · Cited by 982
Oxidative Stress and Neurotoxicity
Sayre, L. M., Perry, G., & Smith, M. A. (2008) · Chemical Research in Toxicology · doi:10.1021/tx700210j · Cited by 867
The Herbicide Paraquat Causes Up-regulation and Aggregation of α-Synuclein in Mice
Manning-Bog, A. B., McCormack, A. L., Li, J., Uversky, V. N., Fink, A. L., & Di Monte, D. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100560200 · Cited by 684
Metadata
- Authors
- Lee, M., Hyun, D., Halliwell, B., & Jenner, P.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2001-02
- Volume
- 76
- Issue
- 4
- Pages
- 998-1009
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1557235501
- Cited by
- 232
- References
- 57
- FWCI
- 19.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.